If you are interested in our services or solutions, please do not hesitate to contact us. We will get back to you as soon as possible.
Contact NowNon-membrane compartments formed by liquid-liquid phase separation (LLPS) are of particular interest because they can concentrate biomolecules and metabolites without the need for complex membranes. Extracellular LLPS are protein-centered, while intracellular condensates typically involve RNA molecules. Protein-protein and protein-RNA interactions drive the assembly of condensates, and some proteins, particularly those with intrinsically disordered regions (IDRs), can form droplets without RNA. Importantly, RNA-only interactions can also drive the formation of condensates. The presence of RNA affects the formation, solubility, and The presence of RNA affects the formation, solubility, and biophysical properties of biomolecular condensates formed by LLPS in a manner that is dependent on RNA length, sequence, structure, modification, and RNA-RNA and RNA-protein interactions.
Fig. 1. Schematic model for biomolecular condensates in the life cycle of RNAs. (Lin Y, et al., 2021)
RNA is one of the key players in LLPS. Our team of experts is dedicated to studying the molecular, thermodynamic and kinetic forces that RNA provides for liquid-liquid phase separation. We can easily observe the topology of RNA-protein condensates from experiments and simulations, and by systematically analyzing the phase behavior of RNA-protein complexes in different mixed components.
Here, CD BioSciences provides you with comprehensive strategies to analyze how RNA drives the formation of phase-separated biomolecular condensates.
By focusing on the intrinsic thermodynamic, kinetic and structural properties of RNA, we provide an important context for understanding and studying the behaviors of different biomolecular condensates. If you are interested in our services, please do not hesitate to contact us for more information.
Reference
CD BioSciences is a company conducting biomolecular condensates targeted innovative drugs. We integrate the latest advances in physics, chemistry, biology, and machine learning to address some of the most fundamental challenges in health and disease today.
Address:
Tel:
Email: